跳至主要内容
临床试验/JPRN-UMIN000051955
JPRN-UMIN000051955已完成Unknown

Prospective observational study to investigate lipid-related residual risks for the patients with acute coronary syndrome who were administrated high-dose strong statin - Investigation of lipid-related residual risks after acute coronary syndrome

Iwate Medical University0 个研究点目标入组 62 人开始时间: 2023年8月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Cases who have a contraindication of rosuvastatin treatment (such as in patients receiving cyclosporine) or requires cautious administration (patients with hypothyroidism or patients planning to use fibrates other than fenofibrate). (2) Cases who have a side effects like muscle pain and poor tolerability to rosuvastatin oral administration. (3) Cases who have already used or have a plan to use other high cholesterol-improving medications (such as evolocumab or ezetimibe) during the observation period. (4) Cases of familial hypercholesterolemia. (5) Cases with chronic inflammatory diseases (autoimmune diseases) or ongoing cancer treatment. (6) Cases with impaired consciousness, general malaise, or severe mental disorders. (7) Other cases who are deemed inappropriate by the investigator.

研究者

相似试验